These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 1009606)
1. [Progesterone in the treatment of endometrial cancer (author's transl)]. Belkov AI; Slot E Cesk Gynekol; 1976 Dec; 41(10):728-9. PubMed ID: 1009606 [No Abstract] [Full Text] [Related]
2. [A case of total regression of endometrial carcinoma metastases in the lung under hormonal therapy (author's transl)]. Caminati M; Hauser GA Ther Umsch; 1979 Jun; 36(6):516-7. PubMed ID: 462406 [No Abstract] [Full Text] [Related]
3. Endometrial cancer as an estrogen-progesterone target. Richardson GS N Engl J Med; 1972 Mar; 286(12):645-7. PubMed ID: 4551276 [No Abstract] [Full Text] [Related]
4. Response of incurable endometrial cancer to progesterone withdrawal. Johnson FL; Muirhead W Can Med Assoc J; 1969 Mar; 100(9):442-3. PubMed ID: 4181226 [No Abstract] [Full Text] [Related]
5. The role of progesterone in human endometrial cancer. Kelley RM; Baker WH Cancer Res; 1965 Aug; 25(7):1190-2. PubMed ID: 5843268 [No Abstract] [Full Text] [Related]
6. [Progesterone and progestagens in the treatment of endometrial cancers. Apropos of a personal case]. Giraud B; Dauplat J J Gynecol Obstet Biol Reprod (Paris); 1974; 3(7):1063-74. PubMed ID: 4470770 [No Abstract] [Full Text] [Related]
8. The status of receptors in the management of endometrial cancer. Richardson GS; MacLaughlin DT Clin Obstet Gynecol; 1986 Sep; 29(3):628-37. PubMed ID: 2944683 [No Abstract] [Full Text] [Related]
9. [The present position of hormone treatment of metastasizing cancer diseases]. Martz G Praxis; 1967 Nov; 56(48):1625-9. PubMed ID: 5632548 [No Abstract] [Full Text] [Related]
10. Progestogen in recurrenct endometrial carcinoma. Mehta A; Shroff M Indian J Cancer; 1966 Dec; 3(4):305-9. PubMed ID: 5977884 [No Abstract] [Full Text] [Related]
11. [On the hormonal treatment of some endometrial cancers]. Monsaingeon A; Aubeny E Ann Chir; 1965; 19(15):1153-60. PubMed ID: 5849805 [No Abstract] [Full Text] [Related]
12. [An innovative protocol, cyclic hormone-chemotherapy in the treatment of high-risk localized endometrial cancer]. Audet-Lapointe P; Ayoub J; Methot Y J Gynecol Obstet Biol Reprod (Paris); 1988; 17(6):751-5. PubMed ID: 3209835 [No Abstract] [Full Text] [Related]
13. [Action of progesterone on endometrial carcinoma (author's transl)]. Szarvas Z Zentralbl Gynakol; 1979; 101(20):1323-8. PubMed ID: 539210 [TBL] [Abstract][Full Text] [Related]
14. Some newer developments in gynecologic cancer. Gray LA J Ark Med Soc; 1974 Aug; 71(3):109-12. PubMed ID: 4276839 [No Abstract] [Full Text] [Related]
16. The influence of progesterone caproate on the enzyme profile of endometrial carcinoma. Thiery M; Willighagen RG Bull Soc R Belge Gynecol Obstet; 1968; 38(1):1-5. PubMed ID: 5746432 [No Abstract] [Full Text] [Related]
17. Cell proliferation kinetics and nuclear morphology in endometrial cancer under progesteron treatment. Siracký J; Schreiner P; Siracká E; Matoska J Neoplasma; 1978; 25(5):535-9. PubMed ID: 740055 [TBL] [Abstract][Full Text] [Related]
18. Use of progestational agents in the management of endometrial cancer. Kistner RW; Griffiths CT; Craig JM Cancer; 1965 Dec; 18(12):1563-79. PubMed ID: 5891823 [No Abstract] [Full Text] [Related]